These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 17188490

  • 1. ERbeta ligands. Part 5: synthesis and structure-activity relationships of a series of 4'-hydroxyphenyl-aryl-carbaldehyde oxime derivatives.
    Mewshaw RE, Bowen SM, Harris HA, Xu ZB, Manas ES, Cohn ST.
    Bioorg Med Chem Lett; 2007 Feb 15; 17(4):902-6. PubMed ID: 17188490
    [Abstract] [Full Text] [Related]

  • 2. ERbeta ligands. Part 2: Synthesis and structure-activity relationships of a series of 4-hydroxy-biphenyl-carbaldehyde oxime derivatives.
    Yang C, Edsall R, Harris HA, Zhang X, Manas ES, Mewshaw RE.
    Bioorg Med Chem; 2004 May 15; 12(10):2553-70. PubMed ID: 15110838
    [Abstract] [Full Text] [Related]

  • 3. Androstenediol analogs as ER-beta-selective SERMs.
    Blizzard TA, Gude C, Morgan JD, Chan W, Birzin ET, Mojena M, Tudela C, Chen F, Knecht K, Su Q, Kraker B, Mosley RT, Holmes MA, Sharma N, Fitzgerald PM, Rohrer SP, Hammond ML.
    Bioorg Med Chem Lett; 2006 Feb 15; 16(4):834-8. PubMed ID: 16309907
    [Abstract] [Full Text] [Related]

  • 4. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 3: synthesis of cyclopentanone and cyclohexanone intermediates for C-ring modification.
    Richardson TI, Dodge JA, Durst GL, Pfeifer LA, Shah J, Wang Y, Durbin JD, Krishnan V, Norman BH.
    Bioorg Med Chem Lett; 2007 Sep 01; 17(17):4824-8. PubMed ID: 17614275
    [Abstract] [Full Text] [Related]

  • 5. Selective estrogen receptor modulators with conformationally restricted side chains. Synthesis and structure-activity relationship of ERalpha-selective tetrahydroisoquinoline ligands.
    Renaud J, Bischoff SF, Buhl T, Floersheim P, Fournier B, Geiser M, Halleux C, Kallen J, Keller H, Ramage P.
    J Med Chem; 2005 Jan 27; 48(2):364-79. PubMed ID: 15658851
    [Abstract] [Full Text] [Related]

  • 6. Monoaryl-substituted salicylaldoximes as ligands for estrogen receptor beta.
    Minutolo F, Bellini R, Bertini S, Carboni I, Lapucci A, Pistolesi L, Prota G, Rapposelli S, Solati F, Tuccinardi T, Martinelli A, Stossi F, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA, Macchia M.
    J Med Chem; 2008 Mar 13; 51(5):1344-51. PubMed ID: 18269232
    [Abstract] [Full Text] [Related]

  • 7. Benzopyrans are selective estrogen receptor beta agonists with novel activity in models of benign prostatic hyperplasia.
    Norman BH, Dodge JA, Richardson TI, Borromeo PS, Lugar CW, Jones SA, Chen K, Wang Y, Durst GL, Barr RJ, Montrose-Rafizadeh C, Osborne HE, Amos RM, Guo S, Boodhoo A, Krishnan V.
    J Med Chem; 2006 Oct 19; 49(21):6155-7. PubMed ID: 17034120
    [Abstract] [Full Text] [Related]

  • 8. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 2: structure-activity relationship studies on the benzopyran scaffold.
    Richardson TI, Norman BH, Lugar CW, Jones SA, Wang Y, Durbin JD, Krishnan V, Dodge JA.
    Bioorg Med Chem Lett; 2007 Jul 01; 17(13):3570-4. PubMed ID: 17485205
    [Abstract] [Full Text] [Related]

  • 9. ERbeta ligands. Part 4: Synthesis and structure-activity relationships of a series of 2-phenylquinoline derivatives.
    Vu AT, Cohn ST, Manas ES, Harris HA, Mewshaw RE.
    Bioorg Med Chem Lett; 2005 Oct 15; 15(20):4520-5. PubMed ID: 16098741
    [Abstract] [Full Text] [Related]

  • 10. Structural evolutions of salicylaldoximes as selective agonists for estrogen receptor beta.
    Minutolo F, Bertini S, Granchi C, Marchitiello T, Prota G, Rapposelli S, Tuccinardi T, Martinelli A, Gunther JR, Carlson KE, Katzenellenbogen JA, Macchia M.
    J Med Chem; 2009 Feb 12; 52(3):858-67. PubMed ID: 19128016
    [Abstract] [Full Text] [Related]

  • 11. Estrogen receptor ligands. II. Discovery of benzoxathiins as potent, selective estrogen receptor alpha modulators.
    Kim S, Wu JY, Birzin ET, Frisch K, Chan W, Pai LY, Yang YT, Mosley RT, Fitzgerald PM, Sharma N, Dahllund J, Thorsell AG, DiNinno F, Rohrer SP, Schaeffer JM, Hammond ML.
    J Med Chem; 2004 Apr 22; 47(9):2171-5. PubMed ID: 15084115
    [Abstract] [Full Text] [Related]

  • 12. Estrogen receptor ligands. Part 6: Synthesis and binding affinity of dihydrobenzodithiins.
    Tan Q, Birzin ET, Chan W, Yang YT, Pai LY, Hayes EC, DaSilva CA, DiNinno F, Rohrer SP, Schaeffer JM, Hammond ML.
    Bioorg Med Chem Lett; 2004 Jul 16; 14(14):3753-5. PubMed ID: 15203156
    [Abstract] [Full Text] [Related]

  • 13. Synthesis of anthranylaldoxime derivatives as estrogen receptor ligands and computational prediction of binding modes.
    Tuccinardi T, Bertini S, Martinelli A, Minutolo F, Ortore G, Placanica G, Prota G, Rapposelli S, Carlson KE, Katzenellenbogen JA, Macchia M.
    J Med Chem; 2006 Aug 10; 49(16):5001-12. PubMed ID: 16884312
    [Abstract] [Full Text] [Related]

  • 14. Synthesis, binding affinity, and transcriptional activity of hydroxy- and methoxy-substituted 3,4-diarylsalicylaldoximes on estrogen receptors alpha and beta.
    Minutolo F, Antonello M, Bertini S, Rapposelli S, Rossello A, Sheng S, Carlson KE, Katzenellenbogen JA, Macchia M.
    Bioorg Med Chem; 2003 Apr 03; 11(7):1247-57. PubMed ID: 12628652
    [Abstract] [Full Text] [Related]

  • 15. Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.
    Malamas MS, Manas ES, McDevitt RE, Gunawan I, Xu ZB, Collini MD, Miller CP, Dinh T, Henderson RA, Keith JC, Harris HA.
    J Med Chem; 2004 Oct 07; 47(21):5021-40. PubMed ID: 15456246
    [Abstract] [Full Text] [Related]

  • 16. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 5: Combined A- and C-ring structure-activity relationship studies.
    Richardson TI, Dodge JA, Wang Y, Durbin JD, Krishnan V, Norman BH.
    Bioorg Med Chem Lett; 2007 Oct 15; 17(20):5563-6. PubMed ID: 17804226
    [Abstract] [Full Text] [Related]

  • 17. Estrogen receptor beta selective ligands: discovery and SAR of novel heterocyclic ligands.
    Chesworth R, Wessel MD, Heyden L, Mangano FM, Zawistoski M, Gegnas L, Galluzzo D, Lefker B, Cameron KO, Tickner J, Lu B, Castleberry TA, Petersen DN, Brault A, Perry P, Ng O, Owen TA, Pan L, Ke HZ, Brown TA, Thompson DD, DaSilva-Jardine P.
    Bioorg Med Chem Lett; 2005 Dec 15; 15(24):5562-6. PubMed ID: 16219463
    [Abstract] [Full Text] [Related]

  • 18. The discovery of tetrahydrofluorenones as a new class of estrogen receptor beta-subtype selective ligands.
    Wilkening RR, Ratcliffe RW, Tynebor EC, Wildonger KJ, Fried AK, Hammond ML, Mosley RT, Fitzgerald PM, Sharma N, McKeever BM, Nilsson S, Carlquist M, Thorsell A, Locco L, Katz R, Frisch K, Birzin ET, Wilkinson HA, Mitra S, Cai S, Hayes EC, Schaeffer JM, Rohrer SP.
    Bioorg Med Chem Lett; 2006 Jul 01; 16(13):3489-94. PubMed ID: 16632357
    [Abstract] [Full Text] [Related]

  • 19. Estrogen receptor ligands: design and synthesis of new 2-arylindene-1-ones.
    McDevitt RE, Malamas MS, Manas ES, Unwalla RJ, Xu ZB, Miller CP, Harris HA.
    Bioorg Med Chem Lett; 2005 Jun 15; 15(12):3137-42. PubMed ID: 15876535
    [Abstract] [Full Text] [Related]

  • 20. Androstene-3,5-dienes as ER-beta selective SERMs.
    Blizzard TA, Gude C, Morgan JD, Chan W, Birzin ET, Mojena M, Tudela C, Chen F, Knecht K, Su Q, Kraker B, Mosley RT, Holmes MA, Rohrer SP, Hammond ML.
    Bioorg Med Chem Lett; 2007 Nov 15; 17(22):6295-8. PubMed ID: 17890084
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.